Ads
related to: fate therapeutics stockinvesco.com has been visited by 1M+ users in the past month
Search results
Fate Therapeutics stock target cut on recent clinical trials updates By Investing.com
Investing.com· 4 days agoOn Friday, BMO (TSX:BMO) Capital Markets adjusted its outlook onFate Therapeutics shares (NASDAQ:...
Earnings call: Fate Therapeutics reports on clinical progress and finances By Investing.com
Investing.com· 1 day agoIn the recent earnings call, Fate Therapeutics (Ticker: NASDAQ:FATE) highlighted significant...
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 5 days agoFate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively,...
Fate Therapeutics Inc (FATE) Shares Plummet Below 1-Year High – News Heater
NewsHeater· 7 days agoFate Therapeutics Inc (NASDAQ: FATE) has experienced a decline in its stock price by -8.06 compared to its previous ...
Fate Therapeutics (NASDAQ:FATE) Cut to Sell at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com lowered shares of Fate Therapeutics (NASDAQ:FATE – Free Report) from a hold rating to a sell rating in a report published ...
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial P
Guru Focus· 4 days agoFate Therapeutics Inc (FATE, Financial) released its 8-K filing on May 9, 2024, detailing its financial results for the first quarter ...
Fate Therapeutics: Q1 Earnings Snapshot
San Francisco Chronicle· 5 days agoSAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Thursday reported...